Zalviso phase 3 orthopedic results published in Anesthesiology demonstrate pain reductions
AcelRx announced results from the IAP311 study were published in Anesthesiology. IAP311 was a randomized, double-blind placebo-controlled, Phase 3 trial evaluating safety and efficacy of Zalviso for treatment of moderate-to-severe post-operative pain following major joint replacement surgery. July 02, 2015